デフォルト表紙
市場調査レポート
商品コード
1425676

非治療用生体分子の世界市場レポート 2024年

Non-Therapeutic Biomolecules Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
非治療用生体分子の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

非治療用生体分子の市場規模は近年急速に拡大しています。2023年の279億1,000万米ドルから2024年には311億1,000万米ドルへと、CAGR11.4%で拡大します。この期間の成長は、研究開発(R&D)への投資拡大、研究・診断への応用拡大、認知度の向上とその後の採用、業界内の戦略的提携やパートナーシップ、この分野の進歩を促進する規制支援など、いくつかの要因に起因しています。

2023年の非治療用生体分子市場シェアでは、アジア太平洋が最大でした。非治療用生体分子市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の非治療用生体分子市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の非治療用生体分子の市場規模実績と成長、2018~2023年
  • 世界の非治療用生体分子市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の非治療用生体分子市場、薬剤別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 酵素
  • 組換えタンパク質
  • プラスミド
  • ペプチド
  • オリゴヌクレオチド
  • モノクローナル抗体
  • 世界の非治療用生体分子市場、エンドユーザー別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 研究
  • 製薬
  • 体外診断薬(IVD)

第7章 地域と国の分析

  • 世界の非治療用生体分子市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の非治療用生体分子市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 非治療用生体分子市場の競合情勢
  • 非治療用生体分子市場の企業プロファイル
    • ABB Ltd.
    • Schneider Electric SE
    • Eaton Corporation plc
    • Larsen &Toubro Ltd.
    • Siemens AG

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

目次
Product Code: r12907

Non-Therapeutic Biomolecules Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-therapeutic biomolecules market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-therapeutic biomolecules? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non-therapeutic biomolecules market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Trad Pharma: Enzymes; Recombinant Proteins; Plasmids; Peptides; Oligonucleotides; Monoclonal Antibodies
  • 2) By End User: Research; Pharma; In vitro diagnostics(IVD)
  • Companies Mentioned: ABB Ltd.; Schneider Electric SE; Eaton Corporation PLC; Larsen & Toubro Ltd.; Siemens AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Non-therapeutic biomolecules encompass a spectrum of organic compounds integral to cellular and organismal functions. These diverse compounds, varying in structure and function, play essential roles in the complex mechanisms governing bodily processes.

The primary classifications of non-therapeutic biomolecules in traditional pharmaceuticals encompass enzymes, recombinant proteins, plasmids, peptides, oligonucleotides, and monoclonal antibodies. Enzymes, for instance, are specialized globular proteins that accelerate biological reactions by lowering the activation energy needed for these processes. These biomolecules find application across diverse sectors including research, pharmaceuticals, and in vitro diagnostics (IVD), contributing significantly to various end-users' operational needs.

The non-therapeutic biomolecules market research report is one of a series of new reports from The Business Research Company that provides non-therapeutic biomolecules market statistics, including the non-therapeutic biomolecules industry's global market size, regional shares, competitors with a non-therapeutic biomolecules market share, detailed non-therapeutic biomolecules market segments, market trends, and opportunities, and any further data you may need to thrive in the non-therapeutic biomolecules industry. This non-therapeutic biomolecules market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The non-therapeutic biomolecules market size has grown rapidly in recent years. It will grow from $27.91 billion in 2023 to $31.11 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth observed in the historical period can be attributed to several factors, including amplified investments in research and development (R&D), expanding applications in research and diagnostics, an increase in awareness and subsequent adoption, strategic collaborations and partnerships within the industry, and regulatory support fostering advancement in the field.

The non-therapeutic biomolecules market size is expected to see rapid growth in the next few years. It will grow to $47.21 billion in 2028 at a compound annual growth rate (CAGR) of 11.0%. The anticipated growth in the upcoming period can be credited to emerging market opportunities, advancements in data analytics and integration, a heightened emphasis on precision medicine, escalating investments in personalized healthcare, and the broadening of application areas within the industry. Key trends expected in this period encompass significant technological advancements, an increase in strategic collaborations, a rising presence in agricultural applications, an expanding role in industrial processes, and an increasing focus on customization and personalization within the field.

The growing volume of research and laboratory assessments is poised to ignite expansion within the non-therapeutic biomolecules market. Laboratory testing involves the analysis of bodily samples like blood or urine to diagnose and monitor diseases, while research involves generating new knowledge or innovatively applying existing concepts. Non-therapeutic biomolecules, integral to laboratory testing, aid in gauging biomarker molecule presence or concentration, amplifying test sensitivity and accuracy. For instance, the American Association for Clinical Chemistry reports that over 200,000 CLIA-certified labs in the US conduct nearly 13 billion tests yearly, with laboratory services constituting 2.3% of healthcare expenses and two percent of Medicare expenditures, thereby fueling the growth of the non-therapeutic biomolecules market.

The surge in healthcare expenditure is anticipated to drive growth in the non-therapeutic biomolecules market. Increased healthcare spending typically translates to amplified funding for medical research and development. Non-therapeutic biomolecules play a crucial role in diagnostic tools and tests. Heightened healthcare investment often signals a stronger emphasis on disease prevention, early detection, and personalized medicine. This heightened focus on diagnostics stands to contribute significantly to the expansion of the non-therapeutic biomolecules market. As evidenced in the Economic Survey of 2022 by the Ministry of Finance, Government of India, the country's healthcare expenditure surged to 2.1% of GDP in 2021-22 from 1.8% in 2020-21, indicating a driving force behind the market's growth during the forecast period.

Product innovation emerges as a prominent trend in the non-therapeutic biomolecules market. Major industry players concentrate on research and development to introduce innovative products, fortifying their market position. An example is BASF SE collaborating with Caregen in January 2022 to unveil the Peptovitae series, employing liposome-encapsulation technology in dermo-cosmetics. This series addresses diverse skin concerns like aging signs, skin brightness enhancement, dryness relief, and moisturization, showcasing the potential of innovative biomolecule applications.

Companies in the non-therapeutic biomolecules sector prioritize developing advanced cell separation technologies for competitive advantage. Notably, Akadeum Life Sciences launched the Microbubble Leukopak Human T Cell Isolation Kit in September 2022, revolutionizing cell separation. This kit utilizes microbubble technology combined with Buoyancy Activated Cell Sorting (BACSTM) Separation Tubes, enhancing productivity by processing double the leukopaks in one-third of the usual time, thereby optimizing laboratory operations.

In July 2021, Eli Lilly and Company, a US-based multinational pharmaceutical company acquired Protomer Technologies for $1 billion. Through this acquisition, Eli Lilly and Company aims to strengthen its product portfolio in biomolecules and accelerate the development of these next-generation therapeutics. Protomer Technologies is a US-based manufacturing and engineering of peptide molecules, including non-therapeutics molecule.

Major companies operating in the non-therapeutic biomolecules market report are ABB Ltd., Schneider Electric SE, Eaton Corporation PLC, Larsen & Toubro Ltd., Siemens AG, LS Electric Co. Ltd., Entec Electric & Electronic Co. Ltd., EPE Switchgear (M) Sdn. Bhd, Lucy Electric Ltd., Ormazabal Corporacion Empresarial S.L., Crompton Greaves Consumer Electricals Limited, Orecco Electric d.o.o, Alfanar Group Ltd., LSIS Co.Ltd., Toshiba Corp., CG Power & Industrial Solutions Ltd., SwitchGear Company NV, NOJA Power Switchgear Pty Ltd., G&W Electric Company, C&S Electric Limited, E+I Engineering Ltd., Hawker Siddeley Switchgear Ltd., Kappa Engineering (Pty) Ltd., KONCAR - Electrical Industry Inc., Laxmi Electronics Pvt. Ltd., MGC Moser-Glaser AG, Mors Smitt B.V, Nissin Electric Co. Ltd., RPS Switchgear Limited, S&S Power Switchgear Limited, Slaters Electricals Ltd., Switchgear Power Systems LLC, Tavrida Electric AG, TE Connectivity Ltd., TGOOD Global Ltd., Trayer Engineering Corporation, VEO Oy, Wahah Electric Supply Company of Saudi Arabia Co., Xiamen Huadian Switchgear Co. Ltd.

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2023. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the non-therapeutic biomolecules market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-therapeutic biomolecule market consists of sales of monosaccharides, disaccharides, polysaccharides, heteropolysaccharides, structural proteins, hormones, respiratory pigments, storage proteins, toxins, deoxyribonucleic acids (DNA), ribonucleic acids (RNA), fatty acids, phospholipids, steroids, eicosanoids, and glycolipids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Non-Therapeutic Biomolecules Market Characteristics

3. Non-Therapeutic Biomolecules Market Trends And Strategies

4. Non-Therapeutic Biomolecules Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Non-Therapeutic Biomolecules Market Size and Growth

  • 5.1. Global Non-Therapeutic Biomolecules Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Non-Therapeutic Biomolecules Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Non-Therapeutic Biomolecules Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Non-Therapeutic Biomolecules Market Segmentation

  • 6.1. Global Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Enzymes
  • Recombinant Proteins
  • Plasmids
  • Peptides
  • Oligonucleotides
  • Monoclonal Antibodies
  • 6.2. Global Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Research
  • Pharma
  • In vitro diagnostics(IVD)

7. Non-Therapeutic Biomolecules Market Regional And Country Analysis

  • 7.1. Global Non-Therapeutic Biomolecules Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Non-Therapeutic Biomolecules Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Non-Therapeutic Biomolecules Market

  • 8.1. Asia-Pacific Non-Therapeutic Biomolecules Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Non-Therapeutic Biomolecules Market

  • 9.1. China Non-Therapeutic Biomolecules Market Overview
  • 9.2. China Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Non-Therapeutic Biomolecules Market

  • 10.1. India Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Non-Therapeutic Biomolecules Market

  • 11.1. Japan Non-Therapeutic Biomolecules Market Overview
  • 11.2. Japan Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Non-Therapeutic Biomolecules Market

  • 12.1. Australia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Non-Therapeutic Biomolecules Market

  • 13.1. Indonesia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Non-Therapeutic Biomolecules Market

  • 14.1. South Korea Non-Therapeutic Biomolecules Market Overview
  • 14.2. South Korea Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Non-Therapeutic Biomolecules Market

  • 15.1. Western Europe Non-Therapeutic Biomolecules Market Overview
  • 15.2. Western Europe Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Non-Therapeutic Biomolecules Market

  • 16.1. UK Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Non-Therapeutic Biomolecules Market

  • 17.1. Germany Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Non-Therapeutic Biomolecules Market

  • 18.1. France Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Non-Therapeutic Biomolecules Market

  • 19.1. Italy Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Non-Therapeutic Biomolecules Market

  • 20.1. Spain Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Non-Therapeutic Biomolecules Market

  • 21.1. Eastern Europe Non-Therapeutic Biomolecules Market Overview
  • 21.2. Eastern Europe Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Non-Therapeutic Biomolecules Market

  • 22.1. Russia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Non-Therapeutic Biomolecules Market

  • 23.1. North America Non-Therapeutic Biomolecules Market Overview
  • 23.2. North America Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Non-Therapeutic Biomolecules Market

  • 24.1. USA Non-Therapeutic Biomolecules Market Overview
  • 24.2. USA Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Non-Therapeutic Biomolecules Market

  • 25.1. Canada Non-Therapeutic Biomolecules Market Overview
  • 25.2. Canada Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Non-Therapeutic Biomolecules Market

  • 26.1. South America Non-Therapeutic Biomolecules Market Overview
  • 26.2. South America Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Non-Therapeutic Biomolecules Market

  • 27.1. Brazil Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Non-Therapeutic Biomolecules Market

  • 28.1. Middle East Non-Therapeutic Biomolecules Market Overview
  • 28.2. Middle East Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Non-Therapeutic Biomolecules Market

  • 29.1. Africa Non-Therapeutic Biomolecules Market Overview
  • 29.2. Africa Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Non-Therapeutic Biomolecules Market Competitive Landscape And Company Profiles

  • 30.1. Non-Therapeutic Biomolecules Market Competitive Landscape
  • 30.2. Non-Therapeutic Biomolecules Market Company Profiles
    • 30.2.1. ABB Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Schneider Electric SE
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Eaton Corporation plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Larsen & Toubro Ltd.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Siemens AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Non-Therapeutic Biomolecules Market Competitive Benchmarking

32. Global Non-Therapeutic Biomolecules Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Non-Therapeutic Biomolecules Market

34. Non-Therapeutic Biomolecules Market Future Outlook and Potential Analysis

  • 34.1 Non-Therapeutic Biomolecules Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Non-Therapeutic Biomolecules Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Non-Therapeutic Biomolecules Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer